Newton cautions that this is an apples to oranges comparison, because the Zocor studies were done with arteries in the neck, not the heart, and more tests are being done to see if ETC-216 reduces plaque in the neck.

FORBES: A Big Win For Esperion

It had the goal of proving that the drug actually reduces the buildup of plaque in the arteries.

FORBES: Pfizer's $13 Billion Bind